Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Farm bill takes effect

This article was originally published in The Tan Sheet

Executive Summary

Federal financial support for herbals and other specialty crops through the farm subsidy programs reauthorization becomes available Sept. 30 as the legislation, H.R. 6124, takes effect with the start of fiscal 2009. The five-year, $289 billion farm bill Congress passed in May over President Bush's veto authorizes $466 million to be appropriated over 10 years to expand the Department of Agriculture's specialty-crop block grant program (1"The Tan Sheet" May 19, 2008, p. 11). The law also requires retailers to provide country-of-origin labeling for raw ginseng as well as for other perishable agricultural commodities, beef and poultry

You may also be interested in...



Farm Bill Grows Herbal Crop Support, But No Vitamins In Food Stamp Program

Congress added financial support for herbals and other specialty crops to the federal farm subsidy programs reauthorization, but omitted multivitamins from food stamp coverage for the second time

Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer

Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025.  It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.

Xaira Launches With $1bn-Plus And End-To-End AI Strategy

ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102093

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel